{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:50:34Z","timestamp":1790898634529,"version":"4.1.0"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["202039WMFP"],"award-info":[{"award-number":["202039WMFP"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["20225M5YEY"],"award-info":[{"award-number":["20225M5YEY"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN2020"],"award-info":[{"award-number":["PRIN2020"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN2022"],"award-info":[{"award-number":["PRIN2022"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejphar.2026.179033","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:43:12Z","timestamp":1780555392000},"page":"179033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ribosome impairment, tau alternative splicing, and stress granules: a convergent axis of neuronal vulnerability driving Alzheimer's disease"],"prefix":"10.1016","volume":"1030","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0919-5206","authenticated-orcid":false,"given":"Mirco","family":"Masi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Oliviero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Govoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Wolozin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Racchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Buoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179033_bib1","article-title":"Editorial: the early detection of neurodegenerative diseases: an aging perspective","volume":"17","author":"Abondio","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejphar.2026.179033_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010810","article-title":"Three repeat isoforms of tau inhibit assembly of four repeat tau filaments","volume":"5","author":"Adams","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179033_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-026-02254-6","article-title":"Unveiling ribosomal dysfunction and impaired signaling pathways in the cortical region of 5xFAD mice","volume":"14","author":"Agrawal","year":"2026","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ejphar.2026.179033_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbadis.2004.08.010","article-title":"Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases","volume":"1739","author":"Andreadis","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2026.179033_bib5","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/jcp.22842","article-title":"Tau splicing and the intricacies of dementia","volume":"227","author":"Andreadis","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2026.179033_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41593-017-0022-z","article-title":"Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo","volume":"21","author":"Apicco","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179033_bib7","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2014188118","article-title":"TIA1 potentiates tau phase separation and promotes generation of toxic oligomeric tau","volume":"118","author":"Ash","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2026.179033_bib8","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1093\/nar\/gkx326","article-title":"Proteomic analysis of polyribosomes identifies splicing factors as potential regulators of translation during mitosis","volume":"45","author":"Aviner","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2026.179033_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2021.112511","article-title":"Attenuation of Pb-induced Abeta generation and autophagic dysfunction via activation of SIRT1: neuroprotective properties of resveratrol","volume":"222","author":"Bai","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.ejphar.2026.179033_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087541","article-title":"GSK-3beta allosteric inhibition: a dead end or a new pharmacological frontier?","volume":"24","author":"Balboni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179033_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer's disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179033_bib12","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1038\/s41598-020-61777-7","article-title":"Tau protein- induced sequestration of the eukaryotic ribosome: implications in neurodegenerative disease","volume":"10","author":"Banerjee","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179033_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrm.2017.27","article-title":"Alternative splicing as a regulator of development and tissue identity","volume":"18","author":"Baralle","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179033_bib14","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1093\/brain\/awx243","article-title":"Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease","volume":"140","author":"Bejanin","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2026.179033_bib15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s40520-019-01360-x","article-title":"Alternative splicing in Alzheimer's disease","volume":"33","author":"Biamonti","year":"2021","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2026.179033_bib16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","article-title":"The distribution of tau in the mammalian central nervous system","volume":"101","author":"Binder","year":"1985","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179033_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/srep30498","article-title":"Internalized Tau sensitizes cells to stress by promoting formation and stability of stress granules","volume":"6","author":"Brunello","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179033_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/biom6010009","article-title":"Nuclear Tau and its potential role in Alzheimer's Disease","volume":"6","author":"Bukar Maina","year":"2016","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2026.179033_bib19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/acel.12057","article-title":"mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies","volume":"12","author":"Caccamo","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejphar.2026.179033_bib20","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2147\/NDT.S75717","article-title":"Activation of mTOR: a culprit of Alzheimer's disease?","volume":"11","author":"Cai","year":"2015","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.ejphar.2026.179033_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/00207454.2013.833510","article-title":"Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease","volume":"124","author":"Cai","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179033_bib22","first-page":"84","article-title":"Rapamycin, autophagy, and Alzheimer's Disease","volume":"1","author":"Cai","year":"2013","journal-title":"J. Biochem. Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2026.179033_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.888420","article-title":"Importin-Mediated pathological tau nuclear translocation causes disruption of the nuclear Lamina, TDP-43 mislocalization and cell death","volume":"15","author":"Candia","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179033_bib24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nicl.2013.02.006","article-title":"Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease","volume":"2","author":"Chetelat","year":"2013","journal-title":"Neuroimage, Clin."},{"key":"10.1016\/j.ejphar.2026.179033_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13024-016-0139-7","article-title":"3D culture models of Alzheimer's disease: a road map to a \"cure-in-a-dish\"","volume":"11","author":"Choi","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2026.179033_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00401-019-02087-9","article-title":"From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy","volume":"139","author":"Colin","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejphar.2026.179033_bib27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","article-title":"Tau-targeting therapies for Alzheimer disease: current status and future directions","volume":"19","author":"Congdon","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2026.179033_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315383","article-title":"Tau isoforms: gaining Insight into MAPT alternative splicing","volume":"23","author":"Corsi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179033_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuron.2008.10.055","article-title":"Translational control of long-lasting synaptic plasticity and memory","volume":"61","author":"Costa-Mattioli","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.179033_bib30","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1016\/j.cell.2025.11.033","article-title":"The evolving landscape of Alzheimer's disease therapy: from Abeta to tau","volume":"188","author":"Courade","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179033_bib31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/acel.12603","article-title":"Methylation of the ribosomal RNA gene promoter is associated with aging and age-related decline","volume":"16","author":"D'Aquila","year":"2017","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejphar.2026.179033_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14463","article-title":"mTOR signaling and Alzheimer's disease: what we know and where we are?","volume":"30","author":"Davoody","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejphar.2026.179033_bib33","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026138","article-title":"The evolution of the ribosomal Protein-MDM2-p53 pathway","volume":"6","author":"Deisenroth","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejphar.2026.179033_bib34","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuron.2012.10.029","article-title":"A plaque-specific antibody clears existing beta-amyloid plaques in Alzheimer's disease mice","volume":"76","author":"Demattos","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.179033_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.179033_bib36","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s40265-021-01569-z","article-title":"Aducanumab: first approval","volume":"81","author":"Dhillon","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2026.179033_bib37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s11064-006-9071-5","article-title":"Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease","volume":"31","author":"Ding","year":"2006","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2026.179033_bib38","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.1523\/JNEUROSCI.3040-05.2005","article-title":"Ribosome dysfunction is an early event in Alzheimer's disease","volume":"25","author":"Ding","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179033_bib39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease","volume":"370","author":"Doody","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179033_bib40","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejphar.2026.179033_bib41","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1128\/MCB.00260-09","article-title":"Phosphorylation of eukaryotic translation initiation factor 2alpha coordinates rRNA transcription and translation inhibition during endoplasmic reticulum stress","volume":"29","author":"DuRose","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179033_bib42","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jamaneurol.2023.3861","article-title":"Exploratory tau biomarker results from a multiple ascending-dose Study of BIIB080 in alzheimer disease: a randomized clinical trial","volume":"80","author":"Edwards","year":"2023","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejphar.2026.179033_bib43","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.neuron.2018.07.039","article-title":"Tau protein disrupts nucleocytoplasmic transport in Alzheimer's disease","volume":"99","author":"Eftekharzadeh","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2026.179033_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2008-14101","article-title":"Differential incorporation of tau isoforms in Alzheimer's disease","volume":"14","author":"Espinoza","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejphar.2026.179033_bib45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/emmm.200900048","article-title":"Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease","volume":"1","author":"Fagan","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejphar.2026.179033_bib46","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.tig.2019.07.004","article-title":"Ribosomopathies: old concepts, new controversies","volume":"35","author":"Farley-Barnes","year":"2019","journal-title":"Trends Genet."},{"key":"10.1016\/j.ejphar.2026.179033_bib47","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/1873-3468.14308","article-title":"Amyloid protein-induced sequestration of the eukaryotic ribosome: effect of stoichiometry and polyphenolic inhibitors","volume":"596","author":"Ferdosh","year":"2022","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2026.179033_bib48","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/459046a","article-title":"Cell biology: Arrest by ribosome","volume":"459","author":"Ferreira-Cerca","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2026.179033_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41582-020-00454-9","article-title":"Aducanumab and the FDA - where are we now?","volume":"17","author":"Fillit","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2026.179033_bib50","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.tins.2020.04.007","article-title":"Resurrecting the mysteries of Big Tau","volume":"43","author":"Fischer","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2026.179033_bib51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-981-32-9358-8_12","article-title":"Emerging connections between Tau and nucleic acids","volume":"1184","author":"Galas","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejphar.2026.179033_bib52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1567205014666170417111859","article-title":"Tau in Alzheimer's disease: mechanisms and therapeutic strategies","volume":"15","author":"Gao","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejphar.2026.179033_bib53","first-page":"15","article-title":"Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model","volume":"6","author":"Garcia-Esparcia","year":"2017","journal-title":"Am J Neurodegener Dis"},{"key":"10.1016\/j.ejphar.2026.179033_bib54","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapy--moving from amyloid-beta to tau","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2026.179033_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/science.1255555","article-title":"NEURODEGENERATION. Alzheimer's and Parkinson's diseases: the prion concept in relation to assembled Abeta, tau, and alpha-synuclein","volume":"349","author":"Goedert","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.179033_bib56","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00412-013-0430-0","article-title":"The nucleolus-guardian of cellular homeostasis and genome integrity","volume":"122","author":"Grummt","year":"2013","journal-title":"Chromosoma"},{"key":"10.1016\/j.ejphar.2026.179033_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.49","article-title":"Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity","volume":"6","author":"Halliday","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2026.179033_bib58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00441-022-03620-1","article-title":"Prion-like strain effects in tauopathies","volume":"392","author":"Han","year":"2023","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejphar.2026.179033_bib59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ana.21425","article-title":"Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"64","author":"Hasegawa","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2026.179033_bib60","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/1873-3468.14723","article-title":"Functions of SRPK, CLK and DYRK kinases in stem cells, development, and human developmental disorders","volume":"597","author":"Hogg","year":"2023","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2026.179033_bib61","article-title":"ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease","volume":"9","author":"Honig","year":"2023","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejphar.2026.179033_bib62","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13195-024-01441-8","article-title":"Updated safety results from phase 3 lecanemab study in early Alzheimer's disease","volume":"16","author":"Honig","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ejphar.2026.179033_bib63","doi-asserted-by":"crossref","first-page":"17781","DOI":"10.1073\/pnas.0909873106","article-title":"AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply","volume":"106","author":"Hoppe","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2026.179033_bib64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.celrep.2019.08.104","article-title":"Tau-Mediated disruption of the spliceosome triggers cryptic RNA splicing and neurodegeneration in Alzheimer's disease","volume":"29","author":"Hsieh","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2026.179033_bib65","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12929-023-00976-6","article-title":"Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update","volume":"30","author":"Huang","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejphar.2026.179033_bib66","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/jcmm.13079","article-title":"Saitohin Q7R polymorphism is associated with late-onset Alzheimer's disease susceptibility among caucasian populations: a meta-analysis","volume":"21","author":"Huang","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2026.179033_bib67","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1080\/15548627.2023.2300917","article-title":"4R tau drives endolysosomal and autophagy dysfunction in frontotemporal dementia","volume":"20","author":"Hung","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.ejphar.2026.179033_bib68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00401-018-1937-5","article-title":"TIA1 regulates the generation and response to toxic tau oligomers","volume":"137","author":"Jiang","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejphar.2026.179033_bib69","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1128\/MCB.20.11.4036-4048.2000","article-title":"Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17","volume":"20","author":"Jiang","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179033_bib70","doi-asserted-by":"crossref","first-page":"18997","DOI":"10.1074\/jbc.M301800200","article-title":"Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta","volume":"278","author":"Jiang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179033_bib71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41392-022-01285-4","article-title":"Ribosome biogenesis in disease: new players and therapeutic targets","volume":"8","author":"Jiao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.179033_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnins.2018.00025","article-title":"Reconsideration of amyloid Hypothesis and Tau Hypothesis in Alzheimer's disease","volume":"12","author":"Kametani","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179033_bib73","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0014-5793(96)01386-5","article-title":"RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments","volume":"399","author":"Kampers","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2026.179033_bib74","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1038\/s41598-018-25767-0","article-title":"TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types","volume":"8","author":"Khalfallah","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179033_bib75","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/bies.20723","article-title":"A new role of the rDNA and nucleolus in the nucleus--rDNA instability maintains genome integrity","volume":"30","author":"Kobayashi","year":"2008","journal-title":"Bioessays"},{"key":"10.1016\/j.ejphar.2026.179033_bib76","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00401-019-01970-9","article-title":"Tau drives translational selectivity by interacting with ribosomal proteins","volume":"137","author":"Koren","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejphar.2026.179033_bib77","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/cdd.2013.66","article-title":"A neuroprotective phase precedes striatal degeneration upon nucleolar stress","volume":"20","author":"Kreiner","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2026.179033_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/life13030604","article-title":"Regulation of Pre-mRNA splicing: indispensable role of post-translational modifications of splicing factors","volume":"13","author":"Kretova","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.ejphar.2026.179033_bib79","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1535-6108(04)00110-2","article-title":"Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation","volume":"5","author":"Kurki","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2026.179033_bib80","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jnr.21850","article-title":"The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity","volume":"87","author":"LaPointe","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2026.179033_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2009-1116","article-title":"The microtubule-associated protein tau is also phosphorylated on tyrosine","volume":"18","author":"Lebouvier","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejphar.2026.179033_bib82","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20241207","article-title":"Early transcriptional effects of inflammatory cytokines reveal highly redundant cytokine networks","volume":"222","author":"Lee","year":"2025","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2026.179033_bib83","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12967-025-06473-8","article-title":"The G-quadruplex ligand CX-5461: an innovative candidate for disease treatment","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2026.179033_bib84","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cellsig.2017.01.010","article-title":"Ribosomal protein pNO40 mediates nucleolar sequestration of SR family splicing factors and its overexpression impairs mRNA metabolism","volume":"32","author":"Lin","year":"2017","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejphar.2026.179033_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218226","article-title":"Abeta-induced damage memory in hCMEC\/D3 cells mediated by Sirtuin-1","volume":"21","author":"Liu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179033_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040936","article-title":"hnRNP A1 regulates alternative splicing of Tau Exon 10 by targeting 3' splice sites","volume":"9","author":"Liu","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179033_bib86","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1326-3-8","article-title":"Tau exon 10 alternative splicing and tauopathies","volume":"3","author":"Liu","year":"2008","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejphar.2026.179033_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013250","article-title":"Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue","volume":"5","author":"Liu-Yesucevitz","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179033_bib89","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/35074506","article-title":"Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus","volume":"3","author":"Llanos","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179033_bib90","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BJ20081501","article-title":"The SR protein family of splicing factors: master regulators of gene expression","volume":"417","author":"Long","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2026.179033_bib91","article-title":"Donanemab (LY3002813) dose-escalation study in Alzheimer's disease","volume":"7","author":"Lowe","year":"2021","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejphar.2026.179033_bib92","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bbrc.2014.10.013","article-title":"Association of microtubule associated protein tau\/Saitohin (MAPT\/STH) MAPT_238bp\/STH Q7R polymorphisms and Parkinson's disease: a meta-analysis","volume":"453","author":"Lu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2026.179033_bib93","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/jcb.20029","article-title":"Tau isoforms which contain the domain encoded by exon 6 and their role in neurite elongation","volume":"91","author":"Luo","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2026.179033_bib94","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1038\/onc.2011.482","article-title":"Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner","volume":"31","author":"Mahata","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2026.179033_bib95","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3389\/fncel.2018.00220","article-title":"The involvement of Abeta42 and Tau in nucleolar and protein synthesis machinery dysfunction","volume":"12","author":"Maina","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179033_bib96","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40478-018-0565-6","article-title":"The involvement of tau in nucleolar transcription and the stress response","volume":"6","author":"Maina","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ejphar.2026.179033_bib97","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006247","article-title":"Biochemistry and cell biology of tau protein in neurofibrillary degeneration","volume":"2","author":"Mandelkow","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejphar.2026.179033_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/cells11162590","article-title":"Proteostasis deregulation in neurodegeneration and its link with stress granules: focus on the scaffold and ribosomal protein RACK1","volume":"11","author":"Masi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179033_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076639","article-title":"The labyrinthine landscape of APP processing: state of the art and possible novel soluble APP-related molecular players in traumatic brain injury and neurodegeneration","volume":"24","author":"Masi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179033_bib100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1101\/gad.333205","article-title":"The nucleolus as a stress sensor: JNK2 inactivates the transcription factor TIF-IA and down-regulates rRNA synthesis","volume":"19","author":"Mayer","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2026.179033_bib101","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1523\/JNEUROSCI.3029-15.2016","article-title":"Pathological Tau promotes neuronal damage by impairing ribosomal function and decreasing protein synthesis","volume":"36","author":"Meier","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179033_bib102","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/molbev\/msy021","article-title":"Revising the structural diversity of ribosomal proteins across the three domains of life","volume":"35","author":"Melnikov","year":"2018","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.ejphar.2026.179033_bib103","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan2755","article-title":"Ribosomopathies: there's strength in numbers","volume":"358","author":"Mills","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.179033_bib104","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer's disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179033_bib105","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s11011-020-00600-8","article-title":"Pathogenesis and promising therapeutics of Alzheimer disease through eIF2alpha pathway and correspondent kinases","volume":"35","author":"Moradi Majd","year":"2020","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ejphar.2026.179033_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2020.151099","article-title":"SRSF3: newly discovered functions and roles in human health and diseases","volume":"99","author":"More","year":"2020","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179033_bib107","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/nar\/gkq758","article-title":"The NIP7 protein is required for accurate pre-rRNA processing in human cells","volume":"39","author":"Morello","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2026.179033_bib108","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/d41573-024-00180-7","article-title":"Anti-tau antibody stumbles in phase II Alzheimer trial","volume":"23","author":"Mullard","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2026.179033_bib109","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","article-title":"Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial","volume":"29","author":"Mummery","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2026.179033_bib110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00401-008-0477-9","article-title":"Phosphorylation of S409\/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies","volume":"117","author":"Neumann","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejphar.2026.179033_bib111","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2026.179033_bib112","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30487-6","article-title":"IL-1beta, IL-6, TNF- alpha and CRP in elderly patients with depression or Alzheimer's disease: systematic review and meta-analysis","volume":"8","author":"Ng","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179033_bib113","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11390","article-title":"Involvement of human ribosomal proteins in nucleolar structure and p53-dependent nucleolar stress","volume":"7","author":"Nicolas","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179033_bib114","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1515\/revneuro-2018-0104","article-title":"Evidence for nucleolar dysfunction in Alzheimer's disease","volume":"30","author":"Nyhus","year":"2019","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179033_bib115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1515\/bmc-2012-0043","article-title":"The nucleolus: a raft adrift in the nuclear sea or the keystone in nuclear structure?","volume":"4","author":"O'Sullivan","year":"2013","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.ejphar.2026.179033_bib116","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrneurol.2017.38","article-title":"Brain imaging: applications of tau PET imaging","volume":"13","author":"Okamura","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejphar.2026.179033_bib117","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abc5429","article-title":"Correction of eIF2-dependent defects in brain protein synthesis, synaptic plasticity, and memory in mouse models of Alzheimer's disease","volume":"14","author":"Oliveira","year":"2021","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejphar.2026.179033_bib118","series-title":"Handbook of the Biology and Pathology of Mental Disorders","first-page":"1777","article-title":"Alzheimer's disease and epigenetics","author":"Orenay-Boyacioglu","year":"2025"},{"key":"10.1016\/j.ejphar.2026.179033_bib119","doi-asserted-by":"crossref","first-page":"9548","DOI":"10.1073\/pnas.1633508100","article-title":"Differential regulation of microtubule dynamics by three- and four-repeat tau: implications for the onset of neurodegenerative disease","volume":"100","author":"Panda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2026.179033_bib120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5483\/BMBRep.2016.49.8.084","article-title":"Tau mis-splicing in the pathogenesis of neurodegenerative disorders","volume":"49","author":"Park","year":"2016","journal-title":"BMB Rep."},{"key":"10.1016\/j.ejphar.2026.179033_bib121","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00109-012-0981-1","article-title":"Nucleolar activity in neurodegenerative diseases: a missing piece of the puzzle?","volume":"91","author":"Parlato","year":"2013","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.ejphar.2026.179033_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2026.02.009","article-title":"Programmable CAR immunotherapies for neurodegenerative proteinopathies","author":"Pesce","year":"2026","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2026.179033_bib123","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fncel.2019.00156","article-title":"Emerging role of the nucleolar stress response in autophagy","volume":"13","author":"Pfister","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179033_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022585","article-title":"Epigenetic silencing of nucleolar rRNA genes in Alzheimer's disease","volume":"6","author":"Pietrzak","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179033_bib125","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJMp2111320","article-title":"Controversy and progress in Alzheimer's disease - FDA approval of aducanumab","volume":"385","author":"Rabinovici","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179033_bib126","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2013.07.038","article-title":"Altered ribostasis: RNA-protein granules in degenerative disorders","volume":"154","author":"Ramaswami","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2026.179033_bib127","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2174\/1567205012666151027124017","article-title":"Differential expression of ribosomal genes in brain and blood of Alzheimer's disease patients","volume":"12","author":"Rasmussen","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.ejphar.2026.179033_bib128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/WAD.0000000000000680","article-title":"An anti-tau therapeutic antibody Etalanetug (E2814): a phase 1, first-in-human (FIH) study of single and multiple ascending doses in healthy subjects","volume":"39","author":"Rawal","year":"2025","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.ejphar.2026.179033_bib129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s40478-021-01268-6","article-title":"Inefficient quality control of ribosome stalling during APP synthesis generates CAT-tailed species that precipitate hallmarks of Alzheimer's disease","volume":"9","author":"Rimal","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ejphar.2026.179033_bib130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3934\/molsci.2015.3.211","article-title":"Role of nucleolar dysfunction in neurodegenerative disorders: a game of genes?","volume":"2","author":"Rosanna","year":"2015","journal-title":"AIMS Molecular Science"},{"key":"10.1016\/j.ejphar.2026.179033_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/cells11050840","article-title":"What's in a gene? The outstanding diversity of MAPT","volume":"11","author":"Ruiz-Gabarre","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2026.179033_bib132","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010140","article-title":"Ribosomal proteins control or bypass p53 during nucleolar stress","volume":"18","author":"Russo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2026.179033_bib133","doi-asserted-by":"crossref","first-page":"7436","DOI":"10.1074\/jbc.M111.298471","article-title":"Amyloid-beta oligomers induce differential gene expression in adult human brain slices","volume":"287","author":"Sebollela","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179033_bib134","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/s41418-018-0076-9","article-title":"The mTOR-S6 kinase pathway promotes stress granule assembly","volume":"25","author":"Sfakianos","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2026.179033_bib135","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00498","article-title":"Pharmacological brake-release of mRNA translation enhances cognitive memory","volume":"2","author":"Sidrauski","year":"2013","journal-title":"eLife"},{"key":"10.1016\/j.ejphar.2026.179033_bib136","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2026.179033_bib137","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12035-016-0336-y","article-title":"Proapoptotic requirement of ribosomal protein L11 in ribosomal stress-challenged cortical neurons","volume":"55","author":"Slomnicki","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.179033_bib138","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1074\/mcp.M115.051920","article-title":"Nucleolar enrichment of brain proteins with critical roles in human neurodevelopment","volume":"15","author":"Slomnicki","year":"2016","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ejphar.2026.179033_bib139","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1074\/jbc.M115.682161","article-title":"Requirement of neuronal ribosome synthesis for growth and maintenance of the dendritic tree","volume":"291","author":"Slomnicki","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2026.179033_bib140","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/archneur.60.5.698","article-title":"Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia","volume":"60","author":"Sobrido","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejphar.2026.179033_bib141","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41392-023-01409-4","article-title":"Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases","volume":"8","author":"Song","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.179033_bib142","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/neup.12275","article-title":"S6 kinase phosphorylated at T229 is involved in tau and actin pathologies in Alzheimer's disease","volume":"36","author":"Sonoda","year":"2016","journal-title":"Neuropathology"},{"key":"10.1016\/j.ejphar.2026.179033_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1094351","article-title":"Trilateral association of autophagy, mTOR and Alzheimer's disease: potential pathway in the development for Alzheimer's disease therapy","volume":"13","author":"Subramanian","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179033_bib144","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","article-title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an Anti-Abeta protofibril antibody","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.ejphar.2026.179033_bib145","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14316","article-title":"Cooperative nuclear action of RNA-binding proteins PSF and G3BP2 to sustain neuronal cell viability is decreased in aging and dementia","volume":"23","author":"Takayama","year":"2024","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejphar.2026.179033_bib146","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-024-01734-2","article-title":"Alternative splicing and related RNA binding proteins in human health and disease","volume":"9","author":"Tao","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.179033_bib147","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1128\/MCB.01174-13","article-title":"Loss of tumor suppressor RPL5\/RPL11 does not induce cell cycle arrest but impedes proliferation due to reduced ribosome content and translation capacity","volume":"33","author":"Teng","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179033_bib148","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gde.2013.02.001","article-title":"Growth control and ribosomopathies","volume":"23","author":"Teng","year":"2013","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.ejphar.2026.179033_bib149","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.tcb.2018.03.007","article-title":"Nucleolar function in lifespan regulation","volume":"28","author":"Tiku","year":"2018","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179033_bib150","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer's disease: pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejphar.2026.179033_bib151","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1101\/gr.122226.111","article-title":"Analysis of alternative splicing associated with aging and neurodegeneration in the human brain","volume":"21","author":"Tollervey","year":"2011","journal-title":"Genome Res."},{"key":"10.1016\/j.ejphar.2026.179033_bib152","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jnc.13037","article-title":"Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD","volume":"133","author":"Tramutola","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2026.179033_bib153","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1096\/fj.14-254680","article-title":"Connecting the nucleolus to the cell cycle and human disease","volume":"28","author":"Tsai","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2026.179033_bib154","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/cdd.2016.37","article-title":"p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration","volume":"23","author":"Turnquist","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2026.179033_bib155","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1111\/j.1742-4658.2011.08274.x","article-title":"Shuttling SR proteins: more than splicing factors","volume":"278","author":"Twyffels","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2026.179033_bib156","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36374-4","article-title":"Phosphorylation of nuclear Tau is modulated by distinct cellular pathways","volume":"8","author":"Ulrich","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179033_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2024.100013","article-title":"Microglial activation states and their implications for Alzheimer's Disease","volume":"12","author":"Valiukas","year":"2025","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.ejphar.2026.179033_bib158","article-title":"Long-term safety and efficacy of lecanemab in early Alzheimer's disease: results from the clarity AD open-label extension study","volume":"21","author":"van Dyck","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.ejphar.2026.179033_bib159","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2026.179033_bib160","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.celrep.2016.04.045","article-title":"Interaction of tau with the RNA-binding protein TIA1 regulates tau pathophysiology and toxicity","volume":"15","author":"Vanderweyde","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2026.179033_bib161","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1523\/JNEUROSCI.1592-12.2012","article-title":"Contrasting pathology of the stress granule proteins TIA-1 and G3BP in tauopathies","volume":"32","author":"Vanderweyde","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179033_bib163","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41392-022-01211-8","article-title":"Epigenetic regulation of aging: implications for interventions of aging and diseases","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2026.179033_bib162","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pneurobio.2008.03.002","article-title":"Microtubule-associated protein tau in development, degeneration and protection of neurons","volume":"85","author":"Wang","year":"2008","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.179033_bib164","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13073-015-0258-8","article-title":"Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease","volume":"8","author":"Watson","year":"2016","journal-title":"Genome Med."},{"key":"10.1016\/j.ejphar.2026.179033_bib165","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798049","article-title":"Tau protein liquid-liquid phase separation can initiate tau aggregation","volume":"37","author":"Wegmann","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2026.179033_bib166","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.18413","article-title":"Distinct stages in stress granule assembly and disassembly","volume":"5","author":"Wheeler","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.ejphar.2026.179033_bib167","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41583-019-0222-5","article-title":"Stress granules and neurodegeneration","volume":"20","author":"Wolozin","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179033_bib168","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.1201262109","article-title":"The chromatin remodeling complex NuRD establishes the poised state of rRNA genes characterized by bivalent histone modifications and altered nucleosome positions","volume":"109","author":"Xie","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2026.179033_bib169","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1626","article-title":"RNA structures in alternative splicing and back-splicing","volume":"12","author":"Xu","year":"2021","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.ejphar.2026.179033_bib170","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1038\/s41598-025-88526-y","article-title":"Alzheimer's disease may develop from changes in the immune system, cell cycle, and protein processing following alterations in ribosome function","volume":"15","author":"Yamakawa","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179033_bib171","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13599","article-title":"A redox mechanism underlying nucleolar stress sensing by nucleophosmin","volume":"7","author":"Yang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2026.179033_bib172","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15698\/cst2018.06.139","article-title":"Nucleolar stress: hallmarks, sensing mechanism and diseases","volume":"2","author":"Yang","year":"2018","journal-title":"Cell Stress"},{"key":"10.1016\/j.ejphar.2026.179033_bib173","doi-asserted-by":"crossref","first-page":"44994","DOI":"10.18632\/oncotarget.16690","article-title":"Meta-analysis of the association between variants in MAPT and neurodegenerative diseases","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2026.179033_bib174","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF02254432","article-title":"Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression","volume":"11","author":"Zheng","year":"2004","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ejphar.2026.179033_bib175","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/0115665240292079240513093708","article-title":"Ribosomal DNA and neurological disorders","volume":"25","author":"Zhou","year":"2025","journal-title":"Curr. Mol. Med."},{"issue":"6","key":"10.1016\/j.ejphar.2026.179033_bib176","article-title":"Alternative splicing: molecular mechanisms, biological functions, diseases, and potential therapeutic targets","author":"Zhu","year":"2025","journal-title":"MedComm"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926005157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926005157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:25:14Z","timestamp":1786235114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926005157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":176,"alternative-id":["S0014299926005157"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179033","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ribosome impairment, tau alternative splicing, and stress granules: a convergent axis of neuronal vulnerability driving Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179033"}}